Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002322915 | SCV002609660 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2023-01-20 | criteria provided, single submitter | clinical testing | The c.3198-330A>G intronic variant results from an A to G substitution 330 nucleotides upstream from coding exon 25 in the NF1 gene. This nucleotide position is conserved on limited sequence alignment. In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice acceptor site; however, direct evidence is insufficient at this time (Ambry internal data). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV004572236 | SCV005052207 | uncertain significance | Juvenile myelomonocytic leukemia | 2024-03-04 | criteria provided, single submitter | clinical testing |